Clinical Trial Update: Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study [Phase 3]

View source ↗

Summary

This Phase 3 pilot trial evaluated adding low-dose aripiprazole to standard therapy for bipolar depression. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Aripiprazole (Abilify) (aripiprazole)

Snippet

Sponsor: Serge Beaulieu | Conditions: Bipolar Disorder, Depressive Episode | Phase 3 | Status: TERMINATED